These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6034073)

  • 1. Alkylating activity of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compounds.
    Wheeler GP; Chumley S
    J Med Chem; 1967 Mar; 10(2):259-61. PubMed ID: 6034073
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the management of patients with advanced breast cancer.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer Chemother Rep; 1972 Feb; 56(1):93-4. PubMed ID: 5030810
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
    Young RC; DeVita VT; Serpick AA; Canellos GP
    N Engl J Med; 1971 Aug; 285(9):475-9. PubMed ID: 5558887
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
    Kinne DW; Humphrey EW
    Cancer Chemother Rep; 1972 Feb; 56(1):53-9. PubMed ID: 5030809
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by vitamin A and caffeine.
    Cohen MH
    J Natl Cancer Inst; 1972 Apr; 48(4):927-32. PubMed ID: 5023690
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A.
    Cohen MH; Carbone PP
    J Natl Cancer Inst; 1972 Apr; 48(4):921-6. PubMed ID: 5023689
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II study of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of bronchogenic carcinoma.
    Olshin S; Siddiqui S; Firat D
    Cancer Chemother Rep; 1972 Apr; 56(2):259-61. PubMed ID: 5043228
    [No Abstract]   [Full Text] [Related]  

  • 8. Gas-chromatographic determination of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU). Part III. Denitrosation to the parent urea.
    Caddy B; Idowu OR
    Analyst; 1982 May; 107(1274):556-65. PubMed ID: 7103097
    [No Abstract]   [Full Text] [Related]  

  • 9. Some effects of 1, 3-bis(2-chloroethyl)-1-nitrosourea upon the synthesis of protein and nucleic acids in vivo and in vitro.
    Wheeler GP; Bowdon BJ
    Cancer Res; 1965 Nov; 25(10):1770-8. PubMed ID: 5859203
    [No Abstract]   [Full Text] [Related]  

  • 10. 2-chloroethanol formation as evidence for a 2-chloroethyl alkylating intermediate during chemical degradation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea.
    Reed DJ; May HE; Boose RB; Gregory KM; Beilstein MA
    Cancer Res; 1975 Mar; 35(3):568-76. PubMed ID: 1116123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037).
    Hansen HH; Selawry OS; Muggia FM; Walker MD
    Cancer Res; 1971 Mar; 31(3):223-7. PubMed ID: 4926242
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
    Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
    Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
    van Eden EB; Falkson G; van Dyk JJ; van der Merwe AM; Falkson HC
    Cancer Chemother Rep; 1972 Feb; 56(1):107-47. PubMed ID: 5030803
    [No Abstract]   [Full Text] [Related]  

  • 14. Antineoplastic agents. 1. Synthesis and antineoplastic activities of chloroethyl- and methylnitrosourea analogues of thymidine.
    Lin TS; Fischer PH; Shiau GT; Prusoff WH
    J Med Chem; 1978 Jan; 21(1):130-3. PubMed ID: 563461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 1,3-bis(2-chlorethyl)-1-nitrosourea (NSC-409962) and nitrogen mustard (NSC-762) on kinetic behavior of cultured L1210 leukemic cells.
    Wilkoff LJ; Dixon GJ; Dulmadge EA; Schabel FM
    Cancer Chemother Rep; 1967 Feb; 51(1):7-18. PubMed ID: 6039664
    [No Abstract]   [Full Text] [Related]  

  • 16. The modes of decomposition of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compounds.
    Montgomery JA; James R; McCaleb GS; Johnston TP
    J Med Chem; 1967 Jul; 10(4):668-74. PubMed ID: 6037060
    [No Abstract]   [Full Text] [Related]  

  • 17. Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas.
    Kohn KW
    Cancer Res; 1977 May; 37(5):1450-4. PubMed ID: 851960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect of pyridine N-oxides having 1-(2-chloroethyl)-1-nitrosoureidoalkyl and 1-methyl-1-nitrosoureidoalkyl groups.
    Miyahara M; Kamiya S; Maekawa A; Odashima S
    Gan; 1979 Dec; 70(6):731-6. PubMed ID: 535684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) with nucleic acids and proteins in vivo and in vitro.
    Cheng CJ; Fujimura S; Grunberger D; Weinstein IB
    Cancer Res; 1972 Jan; 32(1):22-7. PubMed ID: 5007685
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Marsh JC; DeConti RC; Hubbard SP
    Cancer Chemother Rep; 1971 Dec; 55(5):599-606. PubMed ID: 4334161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.